Fusion glycoprotein 92-106 Human respiratory syncytial virus is a synthetic peptide fragment derived from the Human respiratory syncytial virus (HRSV) fusion glycoprotein This peptide is commonly utilized as an antigenic reference in immunological research vaccine design and therapeutic antibody development studies Fusion glycoprotein 92-106 Human respiratory syncytial virus is applied primarily for its immunogenic properties in experimental settings Based on these characteristics Fusion glycoprotein 92-106 Human respiratory syncytial virus holds research potential in immunological assays vaccine development and therapeutic antibody screening related to HRSV